Alcon Inc. (ALC)
ALCNYSEOphthalmic Goods
$70.00
-9.20 (-11.62%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $37.10bn
- P/E
- 21.5
- EPS, last 4 quarters
- $3.26
- Dividend yield
- –
- Day range
- –
- 52-week range
- $61.84 to $87.64
- Average volume
- 1.24m
- Previous close
- $79.20
Analysts
13 coveringBuy8 buy, 4 hold, 1 sell
Targets a year out average $83.67, +19.5% from here
Earnings
next estimate $0.8900Next report
Sep 2025
+2.6%
Dec 2025
-1.3%
Mar 2026
+6.3%
Jun 2026
+9.1%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Alcon Q3 Profit Rises 10%; Tightens FY26 Outlook RTTNews · 3 hours ago
- Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to SayZacks · 4 hours ago
- Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks · 6 days ago
- Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?Zacks · 6 days ago
- Alcon Secures FDA Approval For BRYTLY OTC Redness Relief Eye Drops RTTNews · Oct 16, 2026
- Alcon Becomes Oversold (ALC)BNK Invest · Sep 24, 2026
- Are Options Traders Betting on a Big Move in Alcon Stock?Zacks · Sep 3, 2026
- GKOS Stock Surges 67% Year to Date: What's Driving the Rally?Zacks · Aug 20, 2026
The company
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries and territories each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care.
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Exchange
- NYSE
- Region
- Europe
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.